NanoString nCounter ® Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry.

CONCLUSION: The quantification of ER, PgR, and HER2 mRNA expression with NanoString nCounter® may be a viable alternative to conventional IHC/FISH methods. PMID: 28970855 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/28970855?dopt=Abstract

Source: Journal of Breast Cancer - October 5, 2017 Category: Cancer & Oncology Tags: J Breast Cancer Source Type: research